Sanjiv Sam Gambhir, MD, PhD
Publication Details
-
FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
Mol Imaging Biol. 2011; (2): 362-7
The role of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) was studied in a variety of cancers, including head and neck squamous cell carcinomas (HNSCC) and nasopharyngeal carcinomas (NPC), with several presentations indicating that for these clinical entities a "whole-body" (i.e., eyes to thighs) may yield little additional information. Therefore, we were prompted to review our experience with PET/computed tomography (CT) in the management of patients with HNSCC and NPC.
Help
Trial Administration